Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 12Genitourinary 5Gastrointestinal 5Breast 5Tumor-Agnostic 3Thoracic 3Other solid neoplasm 3Sarcoma 1

Conditions

Solid Tumor, Unspecified, Adult 1Solid Tumor 1Mesothelioma, Malignant 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × rucaparib × Other solid neoplasm × Clear all
NCT04276376 2025-12-01

ARIANES

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated
130 enrolled
Other solid neoplasm

Solid Tumor

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown
186 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT03318445 2021-03-04

Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair

University of California, San Francisco

Phase 1 Completed
22 enrolled
Other solid neoplasm

Solid Tumor, Unspecified, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡